{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T17:50:23Z","timestamp":1790272223379,"version":"4.1.0"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000738","name":"U.S. Department of Veterans Affairs","doi-asserted-by":"publisher","award":["I01 BX000273-07"],"award-info":[{"award-number":["I01 BX000273-07"]}],"id":[{"id":"10.13039\/100000738","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"NINDS","doi-asserted-by":"publisher","award":["UO1 NS074926"],"award-info":[{"award-number":["UO1 NS074926"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Debbie and James Cho Foundation"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurobiology of Disease"],"published-print":{"date-parts":[[2017,8]]},"DOI":"10.1016\/j.nbd.2017.04.019","type":"journal-article","created":{"date-parts":[[2017,4,29]],"date-time":"2017-04-29T04:20:28Z","timestamp":1493439628000},"page":"41-49","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":58,"special_numbering":"C","title":["Simultaneous triple therapy for the treatment of status epilepticus"],"prefix":"10.1016","volume":"104","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1005-0517","authenticated-orcid":false,"given":"Jerome","family":"Niquet","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roger","family":"Baldwin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keith","family":"Norman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucie","family":"Suchomelova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucille","family":"Lumley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claude G.","family":"Wasterlain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nbd.2017.04.019_bb0005","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S0939-6411(03)00041-9","article-title":"Impact of Solutol HS 15 on the pharmacokinetic behavior of midazolam upon intravenous administration to male Wistar rats","volume":"56","author":"Bittner","year":"2003","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.nbd.2017.04.019_bb0010","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S0920-1211(00)00175-3","article-title":"Ketamine controls prolonged status epilepticus","volume":"42","author":"Borris","year":"2000","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.nbd.2017.04.019_bb0015","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.nbd.2014.12.015","article-title":"Effective termination of status epilepticus by rational polypharmacy in the lithium-pilocarpine model in rats: window of opportunity to prevent epilepsy and prediction of epilepsy by biomarkers","volume":"75","author":"Brandt","year":"2015","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2017.04.019_bb0020","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.neuro.2015.05.001","article-title":"Sarin-induced brain damage in rats is attenuated by delayed administration of midazolam","volume":"49","author":"Chapman","year":"2015","journal-title":"Neurotoxicology"},{"key":"10.1016\/j.nbd.2017.04.019_bb0025","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/S1474-4422(06)70374-X","article-title":"Status epilepticus: pathophysiology and management in adults","volume":"5","author":"Chen","year":"2006","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.nbd.2017.04.019_bb0030","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1212\/WNL.46.4.1029","article-title":"A prospective, population-based epidemiologic study of status epilepticus in Richmond, Virginia","volume":"46","author":"DeLorenzo","year":"1996","journal-title":"Neurology"},{"key":"10.1016\/j.nbd.2017.04.019_bb0035","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1007\/s12028-013-9935-x","article-title":"The epidemiology of status epilepticus in the United States","volume":"20","author":"Dham","year":"2014","journal-title":"Neurocrit. Care."},{"key":"10.1016\/j.nbd.2017.04.019_bb0040","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1111\/j.1528-1157.1995.tb00979.x","article-title":"Neuroprotective effect of ketamine administered after status epilepticus onset","volume":"36","author":"Fujikawa","year":"1995","journal-title":"Epilepsia"},{"key":"10.1016\/j.nbd.2017.04.019_bb0045","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1111\/epi.12247","article-title":"Intravenous ketamine for the treatment of refractory status epilepticus: a retrospective multicenter study","volume":"54","author":"Gaspard","year":"2013","journal-title":"Epilepsia"},{"key":"10.1016\/j.nbd.2017.04.019_bb0050","first-page":"24","article-title":"Management of status epilepticus","volume":"31","author":"Gezalian","year":"2014","journal-title":"Fed. Pract."},{"key":"10.1016\/j.nbd.2017.04.019_bb0055","doi-asserted-by":"crossref","first-page":"48","DOI":"10.5698\/1535-7597-16.1.48","article-title":"Evidence-based guideline: treatment of convulsive status epilepticus in children and adults: report of the guideline committee of the American Epilepsy Society","volume":"16","author":"Glauser","year":"2016","journal-title":"Epilepsy Curr."},{"key":"10.1016\/j.nbd.2017.04.019_bb0060","doi-asserted-by":"crossref","first-page":"5511","DOI":"10.1523\/JNEUROSCI.0900-05.2005","article-title":"Status epilepticus increases the intracellular accumulation of GABAA receptors","volume":"25","author":"Goodkin","year":"2005","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2017.04.019_bb0065","doi-asserted-by":"crossref","first-page":"2527","DOI":"10.1523\/JNEUROSCI.3426-07.2008","article-title":"Subunit-specific trafficking of GABA(A) receptors during status epilepticus","volume":"28","author":"Goodkin","year":"2008","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2017.04.019_bb0070","series-title":"Guidance for Industry: Estimating the Maximum Safe Starting Dose in Initial Clinical Trials for Therapeutics in Adult Healthy Volunteers","author":"Guidance","year":"2005"},{"key":"10.1016\/j.nbd.2017.04.019_bb0075","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1136\/jnnp.2004.041947","article-title":"Predictors and prognosis of refractory status epilepticus treated in a neurological intensive care unit","volume":"76","author":"Holtkamp","year":"2005","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.nbd.2017.04.019_bb0080","doi-asserted-by":"crossref","first-page":"7532","DOI":"10.1523\/JNEUROSCI.17-19-07532.1997","article-title":"Rapid seizure-induced reduction of benzodiazepine and Zn2+ sensitivity of hippocampal dentate granule cell GABAA receptors","volume":"17","author":"Kapur","year":"1997","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2017.04.019_bb0085","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1213\/00000539-199308000-00020","article-title":"Effect of anesthetics on neuropathologic sequelae of status epilepticus in rats","volume":"77","author":"Kofke","year":"1993","journal-title":"Anesth. Analg."},{"key":"10.1016\/j.nbd.2017.04.019_bb0090","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.nbd.2009.10.019","article-title":"Vulnerability of postnatal hippocampal neurons to seizures varies regionally with their maturational stage","volume":"37","author":"Lopez-Meraz","year":"2010","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2017.04.019_bb0095","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1111\/j.1528-1167.2007.01384.x","article-title":"A combination of ketamine and diazepam synergistically controls refractory status epilepticus induced by cholinergic stimulation","volume":"49","author":"Martin","year":"2008","journal-title":"Epilepsia"},{"key":"10.1016\/j.nbd.2017.04.019_bb0100","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1001\/archneur.59.2.205","article-title":"Refractory status epilepticus: frequency, risk factors, and impact on outcome","volume":"59","author":"Mayer","year":"2002","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.nbd.2017.04.019_bb0105","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0304-3940(99)00238-4","article-title":"N-methyl-d-asparate receptor antagonists abolish the maintenance phase of self-sustaining status epilepticus in rat","volume":"265","author":"Mazarati","year":"1999","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.nbd.2017.04.019_bb0110","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/S0006-8993(98)01080-4","article-title":"Time-dependent decrease in the effectiveness of antiepileptic drugs during the course of self-sustaining status epilepticus","volume":"814","author":"Mazarati","year":"1998","journal-title":"Brain Res."},{"key":"10.1016\/j.nbd.2017.04.019_bb0115","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.eplepsyres.2004.02.002","article-title":"Anticonvulsant effects of levetiracetam and levetiracetam-diazepam combinations in experimental status epilepticus","volume":"58","author":"Mazarati","year":"2004","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.nbd.2017.04.019_bb0120","doi-asserted-by":"crossref","first-page":"7724","DOI":"10.1523\/JNEUROSCI.4944-04.2005","article-title":"Trafficking of GABA(A) receptors, loss of inhibition, and a mechanism for pharmacoresistance in status epilepticus","volume":"25","author":"Naylor","year":"2005","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2017.04.019_bb0125","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.nbd.2012.12.015","article-title":"Rapid surface accumulation of NMDA receptors increases glutamatergic excitation during status epilepticus","volume":"54","author":"Naylor","year":"2013","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2017.04.019_bb0130","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1111\/epi.13480","article-title":"Midazolam-ketamine dual therapy stops cholinergic status epilepticus and reduces Morris water maze deficits","volume":"57","author":"Niquet","year":"2016","journal-title":"Epilepsia"},{"key":"10.1016\/j.nbd.2017.04.019_bb0135","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1111\/nyas.13147","article-title":"Benzodiazepine-refractory status epilepticus: pathophysiology and principles of treatment","volume":"1378","author":"Niquet","year":"2016","journal-title":"Ann. N. Y. Acad. Sci."},{"issue":"4","key":"10.1016\/j.nbd.2017.04.019_bb0140","doi-asserted-by":"crossref","first-page":"e49","DOI":"10.1111\/epi.13695","article-title":"Treatment of experimental status epilepticus with synergistic drug combinations","volume":"58","author":"Niquet","year":"2017","journal-title":"Epilepsia"},{"key":"10.1016\/j.nbd.2017.04.019_bb0145","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1096\/fj.07-9574LSF","article-title":"Dose translation from animal to human studies revisited","volume":"22","author":"Reagan-Shaw","year":"2008","journal-title":"FASEB J."},{"key":"10.1016\/j.nbd.2017.04.019_bb0150","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1528-1157.1981.tb04327.x","article-title":"Monotherapy or polytherapy for epilepsy?","volume":"22","author":"Reynolds","year":"1981","journal-title":"Epilepsia"},{"key":"10.1016\/j.nbd.2017.04.019_bb0155","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1002\/jnr.22035","article-title":"Contribution of a mitochondrial pathway to excitotoxic neuronal necrosis","volume":"87","author":"Seo","year":"2009","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.nbd.2017.04.019_bb0160","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1056\/NEJMoa1107494","article-title":"Intramuscular versus intravenous therapy for prehospital status epilepticus","volume":"366","author":"Silbergleit","year":"2012","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.nbd.2017.04.019_bb0165","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1203\/01.pdr.0000196333.16608.30","article-title":"Treatment of experimental status epilepticus in immature rats: dissociation between anticonvulsant and antiepileptogenic effects","volume":"59","author":"Suchomelova","year":"2006","journal-title":"Pediatr. Res."},{"key":"10.1016\/j.nbd.2017.04.019_bb0170","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1056\/NEJM199809173391202","article-title":"A comparison of four treatments for generalized convulsive status epilepticus. Veterans Affairs Status Epilepticus Cooperative Study Group","volume":"339","author":"Treiman","year":"1998","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.nbd.2017.04.019_bb0175","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1211\/0022357001773986","article-title":"Effects of lithium on the pharmacokinetics of valproate in rats","volume":"52","author":"Yoshioka","year":"2000","journal-title":"J. Pharm. Pharmacol."}],"container-title":["Neurobiology of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996117301006?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996117301006?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,31]],"date-time":"2024-12-31T20:02:57Z","timestamp":1735675377000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0969996117301006"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8]]},"references-count":35,"alternative-id":["S0969996117301006"],"URL":"https:\/\/doi.org\/10.1016\/j.nbd.2017.04.019","relation":{},"ISSN":["0969-9961"],"issn-type":[{"value":"0969-9961","type":"print"}],"subject":[],"published":{"date-parts":[[2017,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Simultaneous triple therapy for the treatment of status epilepticus","name":"articletitle","label":"Article Title"},{"value":"Neurobiology of Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nbd.2017.04.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}